Method for reducing rejection of allogenic stem cell transplantation

The invention discloses a method for reducing transplantation rejection of allogenic stem cells, the main advantage of the medicine is that the medicine has a unique molecular structure, has a remarkable curative effect on reducing immunological rejection and improving the survival rate and functionality of transplanted stem cells, and provides an effective new scheme for transplantation treatment of allogenic stem cells. 本发明公开了降低异体干细胞移植排斥的方法，本发明药物的主要优势在于其独特的分子结构，在减少免疫排斥、提高移植干细胞的存活率和功能性方面表现出显著的疗效，为异体干细胞移植治疗提供了有效的新方案。